Global mRNA Vaccine And Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 mRNA Vaccine And Therapeutics Market Overview

• 1.1 Product Overview and Scope of mRNA Vaccine And Therapeutics
• 1.2 Classification of mRNA Vaccine And Therapeutics by Types
  • 1.2.1 Global mRNA Vaccine And Therapeutics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Types in 2018
  • 1.2.3 Infectious Disease
  • 1.2.4 Cancer
  • 1.2.5 Others
• 1.3 Global mRNA Vaccine And Therapeutics Market by Application
  • 1.3.1 Global mRNA Vaccine And Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Research Institual
• 1.4 Global mRNA Vaccine And Therapeutics Market by Regions
  • 1.4.1 Global mRNA Vaccine And Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of mRNA Vaccine And Therapeutics (2014-2024)

2 Company Profiles

• 2.1 Moderna Therapeutics
  • 2.1.1 Business Overview
  • 2.1.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Sangamo Therapeutics
  • 2.2.1 Business Overview
  • 2.2.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 eTheRNA
  • 2.3.1 Business Overview
  • 2.3.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 BioNTech
  • 2.4.1 Business Overview
  • 2.4.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Argos Therapeutics
  • 2.5.1 Business Overview
  • 2.5.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 CureVac
  • 2.6.1 Business Overview
  • 2.6.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Translate Bio
  • 2.7.1 Business Overview
  • 2.7.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 In-Cell-Art
  • 2.8.1 Business Overview
  • 2.8.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Ethris
  • 2.9.1 Business Overview
  • 2.9.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Tiba Biotechnology
  • 2.10.1 Business Overview
  • 2.10.2 mRNA Vaccine And Therapeutics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

3 Global mRNA Vaccine And Therapeutics Market Competition, by Players

• 3.1 Global mRNA Vaccine And Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 mRNA Vaccine And Therapeutics Players Market Share
  • 3.2.2 Top 10 mRNA Vaccine And Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Global mRNA Vaccine And Therapeutics Market Size by Regions

• 4.1 Global mRNA Vaccine And Therapeutics Revenue and Market Share by Regions
• 4.2 North America mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)

5 North America mRNA Vaccine And Therapeutics Revenue by Countries

• 5.1 North America mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)

6 Europe mRNA Vaccine And Therapeutics Revenue by Countries

• 6.1 Europe mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Countries

• 7.1 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
• 7.2 China mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)

8 South America mRNA Vaccine And Therapeutics Revenue by Countries

• 8.1 South America mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue mRNA Vaccine And Therapeutics by Countries

• 9.1 Middle East and Africa mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)

10 Global mRNA Vaccine And Therapeutics Market Segment by Type

• 10.1 Global mRNA Vaccine And Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global mRNA Vaccine And Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Infectious Disease Revenue Growth Rate (2014-2024)
• 10.4 Cancer Revenue Growth Rate (2014-2024)
• 10.5 Others Revenue Growth Rate (2014-2024)

11 Global mRNA Vaccine And Therapeutics Market Segment by Application

• 11.1 Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 mRNA Vaccine And Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Research Institual Revenue Growth (2014-2019)

12 Global mRNA Vaccine And Therapeutics Market Size Forecast (2019-2024)

• 12.1 Global mRNA Vaccine And Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global mRNA Vaccine And Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology